Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial

AIM: To determine the efficacy of rectally administered naproxen for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). METHODS: This double-blind randomized control trial conducted from January 2013 to April 2014 at the Gastrointestinal and Liver Diseas...

Full description

Saved in:
Bibliographic Details
Published in:World J Gastroenterol
Main Authors: Mansour-Ghanaei, Fariborz, Joukar, Farahnaz, Taherzadeh, Zahra, Sokhanvar, Homayoon, Hasandokht, Tolou
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2016
Subjects:
Randomized Controlled Trial
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886387/
https://ncbi.nlm.nih.gov/pubmed/27275104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i21.5114
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items